20-63689578-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001283009.2(RTEL1):c.1955T>C(p.Met652Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000494 in 1,612,198 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001283009.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RTEL1 | NM_001283009.2 | c.1955T>C | p.Met652Thr | missense_variant | 23/35 | ENST00000360203.11 | NP_001269938.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RTEL1 | ENST00000360203.11 | c.1955T>C | p.Met652Thr | missense_variant | 23/35 | 5 | NM_001283009.2 | ENSP00000353332.5 | ||
RTEL1 | ENST00000508582.7 | c.2027T>C | p.Met676Thr | missense_variant | 23/35 | 2 | ENSP00000424307.2 | |||
RTEL1 | ENST00000370018.7 | c.1955T>C | p.Met652Thr | missense_variant | 23/35 | 1 | ENSP00000359035.3 | |||
RTEL1-TNFRSF6B | ENST00000492259.6 | n.2039T>C | non_coding_transcript_exon_variant | 21/35 | 5 | ENSP00000457428.1 |
Frequencies
GnomAD3 genomes AF: 0.000329 AC: 50AN: 152116Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000242 AC: 60AN: 248424Hom.: 0 AF XY: 0.000274 AC XY: 37AN XY: 134836
GnomAD4 exome AF: 0.000512 AC: 747AN: 1460082Hom.: 1 Cov.: 32 AF XY: 0.000516 AC XY: 375AN XY: 726320
GnomAD4 genome AF: 0.000329 AC: 50AN: 152116Hom.: 0 Cov.: 33 AF XY: 0.000309 AC XY: 23AN XY: 74314
ClinVar
Submissions by phenotype
not specified Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 21, 2018 | The p.Met676Thr variant in RTEL1 has not been previously reported in individuals with pulmonary fibrosis or dyskeratosis congenita, but has been identified in 0 .05% (62/125316) of European American chromosomes by the Genome Aggregation Data base (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs148080505). Although the variant was observed in the general population, its frequency is not high enoug h to rule out pathogenicity. The variant has also been reported in ClinVar (Vari ation ID:436587). Computational prediction tools and conservation analysis do no t provide strong support for or against an impact to the protein. In summary, th e clinical significance of the p.Met676Thr variant is uncertain. ACMG/AMP Criter ia applied: none. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Nov 24, 2015 | - - |
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Mar 14, 2024 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Published functional studies do not demonstrate a conclusive damaging effect (PMID: 29344583); Also known as c.1955T>C p.M652T; This variant is associated with the following publications: (PMID: 29344583, 30523342) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Jul 19, 2023 | - - |
Dyskeratosis congenita, autosomal recessive 5;C4225346:Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jun 03, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | This sequence change replaces methionine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 652 of the RTEL1 protein (p.Met652Thr). This variant is present in population databases (rs148080505, gnomAD 0.05%). This missense change has been observed in individual(s) with clinical features of RTEL1-related conditions (PMID: 30523342). ClinVar contains an entry for this variant (Variation ID: 436587). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. Experimental studies have shown that this missense change does not substantially affect RTEL1 function (PMID: 29344583). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Dyskeratosis congenita Uncertain:2
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Jan 20, 2020 | - - |
Uncertain significance, criteria provided, single submitter | curation | Sema4, Sema4 | Sep 03, 2021 | - - |
Dyskeratosis congenita, autosomal recessive 5 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Sep 27, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at